Food intolerance products market projected to reach $22.7B by 2031

The global food intolerance products market was valued at $12.1 billion in 2020 and is projected to hit $22.7 billion by 2031, driven by rising celiac disease and lactose intolerance, plus broader demand for vegan, gluten-free and lactose-free foods. North America led revenue in 2020, while Asia-Pacific is forecast to grow fastest through 2031.

Why it matters: - The market is expanding as more consumers seek foods that fit medical needs and lifestyle choices, including lactose-free, gluten-free and vegan products. - The category is also gaining from healthier-eating trends and rising demand for products with clear ingredient and label claims. - Diabetic foods could become a stronger growth pocket as demand rises for lower-sugar alternatives.

What happened: - The global food intolerance products market was valued at $12,145.6 million in 2020. - Allied Market Research projects the market will reach $22,654.4 million by 2031. - The forecast implies a compound annual growth rate of 5.9% from 2022 to 2031. - The report covers product type, distribution channel and region.

The details: - Rising celiac disease and lactose intolerance are major demand drivers. - Health consciousness is increasing adoption of vegan, gluten-free and lactose-free food products. - High product costs remain a drag on market growth. - Urbanization, promotional activity by manufacturers and more attractive packaging are opening new opportunities. - Medical research has improved understanding of immune responses, helping consumers make more informed purchase decisions. - Consumer preference for label claims such as lactose-free and gluten-free continues to support sales. - Lactose-free products have gained share as lactose intolerance has become more common. - Food allergy and intolerance brands are shifting toward dairy-free products to meet demand. - Companies are working to improve the taste, quality and texture of gluten-free products. - According to the clinical practice journal of the American Gastroenterological Association, the global prevalence of celiac disease is 1.4%. - The same source pegs celiac prevalence at 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania. - The market is segmented by type into diabetic food, gluten-free food, lactose-free food and other special milk formula. - The market is segmented by distribution channel into hypermarkets/supermarkets, convenience stores, online channels and others. - The report analyzes North America, Europe, Asia-Pacific and LAMEA. - North America held nearly half of global revenue in 2020. - Asia-Pacific is projected to post the fastest CAGR at 7.1% from 2022 to 2031.

Between the lines: - The biggest demand drivers are shifting from niche dietary needs to mainstream wellness and health-management behavior. - Product differentiation is becoming more important, especially as manufacturers compete on taste and texture as well as health claims. - The regional growth gap suggests mature demand in North America and faster adoption potential in Asia-Pacific.

What's next: - Manufacturers are likely to keep investing in dairy-free, gluten-free and lower-sugar products. - Innovation in formulation and packaging should remain central as brands try to win shelf space and online attention. - Download the sample report for additional market detail. - Request purchase information for buying details.